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by 31% (5). Because stroke is a major cause of dementia, statins
must be considered potentially valuable agents for preventing
cognitive decline in patients with risk factors for atherosclerosis or
dementia.
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Does Inhaled Nitric Oxide Support the
Hemodynamic of Spontaneous Breathing
Patients With Cardiogenic Shock Related to
Right Ventricular Myocardial Infarction?
We read with great interest the echocardiographic study published
by Inglessis et al. (1) concerning hemodynamic effects of inhaled
nitric oxide (NO) in right ventricular myocardial infarction
(RVMI) and cardiogenic shock (CS). They found that inhaled NO
results in acute hemodynamic improvement when administered to
patients with RVMI and CS.
We have a major concern with these results. Indeed, although
10 of 13 patients were under positive pressure ventilation, the
investigators leave the reader with the feeling that inhaled NO
results in significant hemodynamic improvement and a reduction
of right to left shunting when administered to all types of patients.
In our opinion, we may expect that the observed NO effect
could not be shown in spontaneous breathing patients. Indeed, as
stated by the researchers, breathing NO is thought to increase
pulmonary venous return and left ventricular filling pressure when
cardiac output is decreased (2). Because positive pressure ventila-
tion acts as a circulatory pump (3) and decreases left ventricular
transmural pressure, acute left ventricular failure may occur when
the lungs are not mechanically assisted.
In this setting, we suggest to Inglessis et al. (1) not to extend
their conclusions regarding the hemodynamic inhaled NO effects
to spontaneous ventilated patients with acute RVMI and CS.
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We thank Dr. Bendjelid for his interest in our work (1). We agree
that the majority of our patients were studied while undergoing
positive pressure ventilation. As only three patients in our study
population did not require mechanical ventilation, our ability to
extrapolate our results to patients with right ventricular myocardial
infarction (RVMI) not receiving mechanical ventilation is limited.
Nonetheless, there was no difference in the improvement in cardiac
index observed between those patients breathing nitric oxide (NO)
who were mechanically ventilated and those who were not.
Dr. Bendjelid also raises the concern that positive pressure
ventilation may act to prevent the development of acute left
ventricular (LV) failure that may occur during NO inhalation, and
that LV failure may arise in nonventilated patients. Left ventricular
filling pressures have been found to increase during NO inhalation
in patients with severe LV systolic dysfunction (2,3). The RVMI
patients in our study had primarily RV dysfunction, and the degree
of LV dysfunction was not as severe as in those patients in whom
the pulmonary capillary wedge pressure (PCWP) has been re-
ported to increase during NO inhalation. Furthermore, we ex-
cluded patients with a PCWP 25 mm Hg from study. In the
three nonventilated RVMI patients in our study, we did not
observe an increase in their PCWP while they were breathing NO
for 10 min.
In future studies of the effects of sustained NO inhalation in
RVMI patients, it will be important to observe the hemodynamic
effects of this agent in patients who receive positive pressure
ventilation as well as those who do not. Patients with severe LV
systolic function should be monitored carefully during chronic NO
inhalation because of the possibility of their developing pulmonary
venous hypertension.
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Patient Alert and Cardiac Defibrillators
Becker et al. (1) recently analyzed the utility of patient-alert
features in implantable cardioverter-defibrillators (ICDs). Most
modern ICD devices monitor certain parts of the defibrillation
system, including lead impedance and battery status, continuously.
In case of adverse incidents (e.g., unexpected decrease or increase
in lead impedance, premature battery depletion) the device pro-
duces acoustic warning signals, and the system needs to be checked
by the doctor. The researchers concluded that such patient-alert
features are useful additional tools facilitating early detection of
serious ICD complications, but they may have low sensitivity.
We wish to report a case to illustrate that such patient-alert
features may confuse both the patient and the physician. A
62-year-old man was referred to an otorhinolaryngologist because
of a four-day history of recurrent short episodes of tinnitus. He had
a history of anterior myocardial infarction nine years ago. Subse-
quently, echocardiography revealed severe left ventricular dysfunc-
tion. The patient underwent implantation of a defibrillator because
of recurrent ventricular tachycardia four months ago. Otolaryngo-
logic examination was normal. When the patient thoroughly
described his medical history and his perception of the recurrent
ringing sound in his ears and head, the otolaryngologist considered
the presence of an external sound. Although, the otolaryngologist
was not aware of the monitor systems within ICDs that sound in
case of adverse incidents, he referred the patient to the cardiologist
to check the defibrillator. Evaluation of the defibrillator by
telemetry revealed unexpected increase in lead impedance requir-
ing immediate surgical revision (2).
Because ICDs have been clearly documented to revert sustained
ventricular tachyarrhythmias, including pace termination of sus-
tained ventricular tachycardia and shock reversion of ventricular
fibrillation, the number of patients treated with such devices for
secondary and primary prevention increases rapidly. Thus, ICD
patients should be informed in detail about the various features and
tools of their device including patient-alert systems. Additionally,
both training and education for ICDs are required not only for
cardiologists and general practitioners but for other professionals
within the medical community.
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In their Letter to the Editor, Auer and colleagues reported the case
of an implantable cardioverter-defibrillator (ICD) patient with
suspected tinnitus who presented to an ear-nose-throat (ENT)
specialist. Although unaware of the patient-alert feature, the ENT
doctor suspected an external sound rather than tinnitus and
referred the patient to the cardiologist, who checked the patient’s
defibrillator and found that an increase in lead impedance had
triggered the patient-alert function. The impedance rise obviously
reflected severe lead dysfunction requiring immediate surgical
revision. The investigators conclude that training and education
about various ICD features including patient alert should be
provided to both patients and physicians. We believe that educat-
ing the entire medical community to various ICD features is hardly
feasible, but undoubtedly it makes no sense to activate features
such as patient alert without educating the patients. During
routine postimplant ICD programming, the alert signal should be
demonstrated to the patient (as available via programmer teleme-
try) and the alert time should be discussed and individually adapted
to the patient’s waking hours. If this becomes part of the clinical
routine, as in our center, the patient-alert feature may well be a
useful additional tool that facilitates early detection of system-
related complications (1). Moreover, even in the case presented by
Auer and colleagues, the alert feature served to disclose a severe
lead complication that otherwise would have been diagnosed only
at the next routine follow-up visit.
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